Lithuanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Puslapis 1 nuo 357 rezultatus
Nausea, vomiting and diarrhea: an unusual presentation of multiple sclerosis.
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
The case of a young woman who presented with nausea, vomiting and diarrhea is outlined; the etiology turned out to be a first attack of multiple sclerosis. Plausible mechanisms are discussed.
The cannabinoids: an overview. Therapeutic implications in vomiting and nausea after cancer chemotherapy, in appetite promotion, in multiple sclerosis and in neuroprotection.
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
The present paper describes the historical use of cannabis, starting with its use in Assyria and China. Recent advances in the understanding of the molecular basis of cannabis action are explained, including the identification of the cannabinoid receptors CB(1) and CB(2), as well as the isolation of
Visually induced paroxysmal nausea and vomiting as presenting manifestations of multiple sclerosis.
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Visually induced paroxysmal nausea and vomiting as presenting manifestations of multiple sclerosis.
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Both paracetamol and ibuprofen are equally effective in managing flu-like symptoms in relapsing-remitting multiple sclerosis patients during interferon beta-1a (AVONEX) therapy.
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Interferon beta-1a is an established therapy for patients with relapsing-remitting multiple sclerosis (MS). Adverse effects in the first weeks of treatment are common. This open-label, multicenter, randomized, prospective study compared treatment of flu-like symptoms (FLS) with paracetamol versus
Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects.
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Cyclophosphamide is an alkylating agent used to treat malignancies and immune-mediated inflammatory non-malignant processes such as lupus nephritis and immune-mediated neuropathies. It has been studied as a treatment for multiple sclerosis (MS) for the past 30 years and is used by physicians in
The safety profile of cyclophosphamide in multiple sclerosis therapy.
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Cyclophosphamide (Cyc) is an alkylating agent used to treat malignancies and autoimmune diseases, such as lupus nephritis, rheumatoid arthritis and immune-mediated neuropathies. Over the past 40 years, Cyc has also been applied to treat multiple sclerosis (MS) and the effective stabilisation of
Mitoxantrone in relapsing-remitting and rapidly progressive multiple sclerosis: Ten-year clinical outcomes post-treatment with mitoxantrone
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Background: Mitoxantrone (MTX) has been used as an effective disease modifying treatment (DMT) in multiple sclerosis (MS). Evidence from studies demonstrates benefits of reduced relapse rates, MRI disease activity and disability
Off-label use of aprepitant for scleroderma-associated nausea and vomiting: A case report.
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Systemic therapy with calcitonin has positive clinical effects on systemic sclerosis in patients with cutaneous manifestations.
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
BACKGROUND
Calcitonin gene-related peptide (CGRP) is a vasodilatory neuropeptide that plays an important role in the blood vessels of heart and peripheral circulation, a lack of which may cause vasculopathies.
OBJECTIVE
In this study, the clinical course of disease, as well as the efficacy, side
Immunosuppression with high-dose i.v. cyclophosphamide and ACTH in progressive multiple sclerosis: cumulative 6-year experience in 164 patients.
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
One hundred sixty-four patients with chronic progressive multiple sclerosis (MS) have been treated with a regimen of high-dose IV cyclophosphamide and ACTH over the past 6 years. Their status was reviewed to determine complications associated with treatment, dosage of medication used to induce a
Cryptococcal meningitis in a patient with multiple sclerosis on dimethyl fumarate treatment: A case report.
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
INTRODUCTION
We present a case of meningitis caused by Cryptococcus neoformans var. grubii in a 46-year old non-HIV-infected patient with multiple sclerosis, treated with dimethyl fumarate monotherapy. We identified no other risk factors for developing cryptococcal meningitis.Multiple sclerosis as a cause of the acute vestibular syndrome.
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Multiple sclerosis (MS) causes dizziness and vertigo. Reports suggest responsible lesions are often in the intra-pontine 8th nerve fascicle. We sought to determine frequency and clinical features of demyelinating acute vestibular syndrome (AVS). This is a prospective observational study (1999-2011).
Low-dose intravenous cyclophosphamide in systemic sclerosis: a preliminary safety study.
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Both oral and intravenous high-dose cyclophosphamide (CYC) regimens are associated with serious side effects when used for the treatment of systemic sclerosis (SSc). The aim of the present trial was to test the safety of low-dose intravenous CYC in patients with SSc. Eight SSc patients, in whom CYC
Acute respiratory failure with gross hemoptysis in a patient with lymphangioleiomyomatosis as part of tuberous sclerosis complex.
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
A 29-year-old woman was admitted to our hospital with a 7-day history of elevated temperature to 39.5 degrees C associated with headache and nausea. She had been diagnosed with tuberous sclerosis complex 10 years earlier. Her unconsciousness progressed, and she was diagnosed as having aseptic
Išsamiausia vaistinių žolelių duomenų bazė, paremta mokslu
- Dirba 55 kalbomis
- Žolelių gydymas, paremtas mokslu
- Vaistažolių atpažinimas pagal vaizdą
- Interaktyvus GPS žemėlapis - pažymėkite vaistažoles vietoje (netrukus)
- Skaitykite mokslines publikacijas, susijusias su jūsų paieška
- Ieškokite vaistinių žolelių pagal jų poveikį
- Susitvarkykite savo interesus ir sekite naujienas, klinikinius tyrimus ir patentus
Įveskite simptomą ar ligą ir perskaitykite apie žoleles, kurios gali padėti, įveskite žolę ir pamatykite ligas bei simptomus, nuo kurių ji naudojama.
* Visa informacija pagrįsta paskelbtais moksliniais tyrimais
